These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 93770

  • 1. [Immunotherapy today. II. Immunostimulating therapy].
    D'Amelio R.
    Riv Med Aeronaut Spaz; 1978; 41(1):75-114. PubMed ID: 93770
    [No Abstract] [Full Text] [Related]

  • 2. Immune modulators as antiviral agents.
    Steele RW, Charlton RK.
    Clin Lab Med; 1987 Dec; 7(4):911-24. PubMed ID: 2446821
    [Abstract] [Full Text] [Related]

  • 3. [Concepts of stimulating immunotherapy].
    Aiuti F, Montella F.
    Minerva Med; 1982 Apr 07; 73(15):895-8. PubMed ID: 6176915
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunopharmacologic bases of immunotherapy.
    Hadden JW, Keskiner Merriam L.
    Clin Physiol Biochem; 1985 Apr 07; 3(2-3):111-9. PubMed ID: 2408810
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of immunostimulating agents on viral infections.
    Zerial A, Werner GH.
    Acta Microbiol Acad Sci Hung; 1981 Apr 07; 28(3):325-37. PubMed ID: 6171144
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of the primary immunodeficiency diseases. Present state of the art (author's transl)].
    Fontán G, García Rodríguez MC, Ojeda JA.
    An Esp Pediatr; 1981 Dec 07; 15(6):563-72. PubMed ID: 6175263
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Thymic humoral factor (THF) therapy in a patient with Di-George syndrome.
    Ersoy F, Sanal O, Yeğin O, Berkel AI, Cağlar M.
    Turk J Pediatr; 1982 Dec 07; 23(2):115-20. PubMed ID: 7201177
    [No Abstract] [Full Text] [Related]

  • 12. Thymopentin (TP-5) in the treatment of the postburn and postoperative immunodeficiency syndrome.
    Hamilton G, Zöch G, Rath T, Meissl G.
    Prog Clin Biol Res; 1989 Dec 07; 308():995-9. PubMed ID: 2528748
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical value of immunotherapy for gynecological cancer by BRM (biological response modifier)].
    Akiya K, Negishi Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun 07; 37(6):1025-9. PubMed ID: 2410519
    [No Abstract] [Full Text] [Related]

  • 14. [Immunomodulating treatment of patients with HIV infection].
    Skotnicki AB, Kornaszewski W.
    Przegl Dermatol; 1989 Jun 07; 76(4):285-91. PubMed ID: 2483589
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of dysfunction of cellular immunity and the prospect for future].
    Igarashi T, Azuma I, Yamamura Y.
    Nihon Rinsho; 1978 Jun 07; 36(5):1011-7. PubMed ID: 353324
    [No Abstract] [Full Text] [Related]

  • 16. Experience gained in immunotherapy from the immunopharmacology of BCG leading to a second generation of systemic immunity adjuvants.
    Mathe G.
    Comp Immunol Microbiol Infect Dis; 1980 Jun 07; 3(4):407-32. PubMed ID: 6451350
    [No Abstract] [Full Text] [Related]

  • 17. Thymic hormone in the treatment of cancer.
    Dardeene M, Bach JF.
    Prog Clin Biol Res; 1989 Jun 07; 288():363-82. PubMed ID: 2654955
    [No Abstract] [Full Text] [Related]

  • 18. Thymopentin in dermatology.
    Haneke E.
    Curr Probl Dermatol; 1989 Jun 07; 18():283-9. PubMed ID: 2663371
    [No Abstract] [Full Text] [Related]

  • 19. Immunostimulation and host resistance against infection: therapeutic perspectives.
    Fauve RM.
    Adv Nephrol Necker Hosp; 1980 Jun 07; 9():167-86. PubMed ID: 6157316
    [No Abstract] [Full Text] [Related]

  • 20. [Immunostimulants].
    Lesavre P, Bach JF.
    Rev Prat; 1980 Mar 11; 30(15):907-8, 911-5. PubMed ID: 6154961
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.